This phase II trial studies the effect of a wearable technology device monitoring sun exposure on sun protection behaviors and UV exposure in melanoma survivors. Previous research suggests that while some melanoma survivors change their health behaviors (physical activity, nutrition, sun exposure), many do not. Melanoma survivors, like other cancer survivors, are at risk of second cancer, making it critical that they make healthy choices. The wearable device may improve sun protection behaviors and reduce ultraviolet exposure and sunburns in melanoma survivors.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT03927742.
PRIMARY OBJECTIVE:
I. To evaluate the effectiveness of a (ultraviolet radiation) UVR-sensor wearable device intervention to improve sun protection behaviors and reduce UV exposure and sunburns in a randomized controlled trial in melanoma survivors.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM I: Patients wear UVR-sensor enabled wearable band for 12 weeks that collects UVR exposure and provides prompts when approaching the daily limit and alert once they reach 20% of their daily limit (and every 20% after that) via a notification on patients' phone. Patients also use an information website on melanoma and numerous health behaviors, including physical activity and sun exposure and protection.
ARM II: Patients wear UVR-sensor enabled wearable band for 12 weeks that collects UVR exposure. Patients also use an information website on melanoma and numerous health behaviors, including physical activity and sun exposure and protection.
After completion of study, patients are followed up at 64 weeks.
Lead OrganizationUniversity of Minnesota/Masonic Cancer Center
Principal InvestigatorRachel I Vogel
